Clinical Study to Evaluate the Exercise Capacity in Patients With Severe Emphysema Treated With Coils
CYCLONE
1 other identifier
interventional
35
1 country
1
Brief Summary
The study hypothesis is that patients with homogeneous emphysema behave differently compared to heterogeneous emphysema with respect to exercise capacity. A better understanding of this difference will allow the investigators to choose the best treatment for each type of patient. The main purpose of this study is to evaluate the change in exercise capacity measured by cycle ergometry in patients with severe emphysema after endoscopic lung volume reduction with coils (eLVR). As a secondary purpose, the investigators want to perform an exploratory, randomized study to compare the results of two different therapeutic approaches in a small sample of patients with homogeneous emphysema.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2016
CompletedFirst Posted
Study publicly available on registry
August 25, 2016
CompletedStudy Start
First participant enrolled
November 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedMarch 1, 2019
February 1, 2019
4.8 years
July 29, 2016
February 28, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Inspiratory Capacity (L)
Change in Inspiratory Capacity (L) at 6 months from baseline
three months before procedure and six months after first procedure
Secondary Outcomes (7)
RV (L)
three months before procedure and six months after first procedure
6-MWT (m)
three months before procedure and six months after first procedure
SGQLT (measured in points)
three months before procedure and six months after first procedure
FEV1(measured in liters)
three months before procedure and six months after first procedure
FVC (measured in liters)
three months before procedure and six months after first procedure
- +2 more secondary outcomes
Study Arms (2)
10 coils in upper lobes
ACTIVE COMPARATOR10 coils in upper lobes
15 coils in upper and lower lobes
EXPERIMENTAL15 coils in upper and lower lobes
Interventions
Eligibility Criteria
You may qualify if:
- Emphysematous patient
- FEV1 \< 50%
- RV \> 200%
- Diffusion \<60% \>20%
- PSP \<55 mmHg
You may not qualify if:
- Anticoagulants/antiplatelets
- Giant bullae (\> 8 cm , 1/3 hemithorax)
- More tan three moderate/severe exacerbation per year
- Negative to sign informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fundación Jiménez Díaz
Madrid, 28040, Spain
Related Publications (4)
Hartman JE, Klooster K, Ten Hacken NH, Slebos DJ. Treatment of emphysema using bronchoscopic lung volume reduction coil technology: an update on efficacy and safety. Ther Adv Respir Dis. 2015 Oct;9(5):251-9. doi: 10.1177/1753465815589904. Epub 2015 Jun 25.
PMID: 26113524BACKGROUNDDeslee G, Klooster K, Hetzel M, Stanzel F, Kessler R, Marquette CH, Witt C, Blaas S, Gesierich W, Herth FJ, Hetzel J, van Rikxoort EM, Slebos DJ. Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax. 2014 Nov;69(11):980-6. doi: 10.1136/thoraxjnl-2014-205221. Epub 2014 Jun 2.
PMID: 24891327BACKGROUNDBoutou AK, Zoumot Z, Nair A, Davey C, Hansell DM, Jamurtas A, Polkey MI, Hopkinson NS. The Impact of Homogeneous Versus Heterogeneous Emphysema on Dynamic Hyperinflation in Patients With Severe COPD Assessed for Lung Volume Reduction. COPD. 2015;12(6):598-605. doi: 10.3109/15412555.2015.1020149. Epub 2015 Sep 23.
PMID: 26398112BACKGROUNDAros F, Boraita A, Alegria E, Alonso AM, Bardaji A, Lamiel R, Luengo E, Rabadan M, Alijarde M, Aznar J, Bano A, Cabanero M, Calderon C, Camprubi M, Candell J, Crespo M, de la Morena G, Fernandez A, Ferrero JA, Gayan R, Bolao IG, Hernandez M, Maceira A, Marin E, Muela de Lara A, Placer L, San Roman JA, Serratosa L, Sosa V, Subirana MT, Wilke M. [Guidelines of the Spanish Society of Cardiology for clinical practice in exercise testing]. Rev Esp Cardiol. 2000 Aug;53(8):1063-94. Spanish.
PMID: 10956604BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Iker Fernandez-Navamuel, MD, PhD
FJD
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 29, 2016
First Posted
August 25, 2016
Study Start
November 1, 2016
Primary Completion
September 1, 2021
Study Completion
December 1, 2021
Last Updated
March 1, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share